NIH Reporter #11375807

Research Grant for Structural Biology and Nanobody Development Targeting APOBEC Enzymes

This opportunity is a research grant offered by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), focused on advancing cancer therapeutics through structural biology and nanobody development targeting APOBEC enzymes. - Government Buyer: - National Cancer Institute (NCI), National Institutes of Health (NIH), United States - Associated with the University of Minnesota, Minneapolis, MN - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or vendors are named in the notice - Products/Services Requested: - Research in structural biology and nanobody development - Focus on APOBEC enzyme inhibition and structural dynamics - No specific products, part numbers, or purchase quantities are listed - Unique or Notable Requirements: - Emphasis on cancer therapeutics applications - Research must address structural dynamics and nanobody interactions with viral proteins - Total award amount is $35,827 - No commercial product procurement; this is a research-focused grant

Description

This is a research grant opportunity focusing on structural biology and nanobody development related to APOBEC enzymes, with a focus on cancer therapeutics. The project is funded by the National Cancer Institute (NCI), part of NIH. The total award amount is $35,827 for fiscal year 2026. The project duration is from July 1, 2025, to June 30, 2027. The research is associated with the University of Minnesota in Minneapolis, MN.

View original listing